Photodiagnosis and Photodynamic Therapy
Volume 5, Issue 2 , Pages 153-158 , June 2008

The economic benefit of photodynamic diagnosis in non-muscle invasive bladder cancer

References 

  1. Lee R, Droller MJ. The natural history of bladder cancer. Implications for therapy. Urol Clin North Am. 2000;27(1):1–13vii
  2. Schellhammer PF. Immediate adjuvant intravesical chemotherapy after transurethral resection of bladder tumour. Curr Opin Urol. 1998;8(5):407–409
  3. Holzbeierlein JM, Smith JA. Surgical management of noninvasive bladder cancer (stages Ta/T1/CIS). Urol Clin North Am. 2000;27(1):15–24vii–viii
  4. Vogeli TA, Grimm MO, Simon X, Ackermann R. Prospective study of effectiveness. Reoperation (re-TUR) in superficial bladder carcinoma. Urologe A. 2002;41(5):470–474
  5. Klan R, Loy V, Huland H. Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. J Urol. 1991;146(2):316–318
  6. Soloway MS, Murphy W, Rao MK, Cox C. Serial multiple-site biopsies in patients with bladder cancer. J Urol. 1978;120(1):57–59
  7. Althausen AF, Prout GR, Daly JJ. Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. J Urol. 1976;116(5):575–580
  8. Kappas A, Sassa S, Galbraith R, Nordmann Y. The porphyrias. In: Scriver C, Beaudet W, Sly D, Valle D, editors. New York: McGraw-Hill; 1989. p. 1305–66.
  9. Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B. 1992;14(4):275–292
  10. Sima AA, Kennedy JC, Blakeslee D, Robertson DM. Experimental porphyric neuropathy: a preliminary report. Can J Neurol Sci. 1981;8(2):105–113
  11. Pottier RH, Chow YF, LaPlante JP, Truscott TG, Kennedy JC, Beiner LA. Non-invasive technique for obtaining fluorescence excitation and emission spectra in vivo. J Photochem Photobiol B. 1986;44:679–687
  12. Kriegmair M, Baumgartner R, Knuechel R, et al. Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. Urology. 1994;44(6):836–841
  13. Steinbach P, Kriegmair M, Baumgartner R, Hofstadter F, Knuchel R. Intravesical instillation of 5-aminolevulinic acid: the fluorescent metabolite is limited to urothelial cells. Urology. 1994;44(5):676–681
  14. Zaak D, Kriegmair M, Stepp H, et al. Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: results of 1012 fluorescence endoscopies. Urology. 2001;57(4):690–694
  15. Kriegmair M, Baumgartner R, Knuchel R, Stepp H, Hofstadter F, Hofstetter A. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J Urol. 1996;155(1):105–109
  16. Jichlinski P, Forrer M, Mizeret J, et al. Clinical evaluation of a method for detecting superficial surgical transitional cell carcinoma of the bladder by light-induced fluorescence of protoporphyrin IX following the topical application of 5-aminolevulinic acid: preliminary results. Lasers Surg Med. 1997;20(4):402–408
  17. Filbeck T, Roessler W, Knuechel R, Straub M, Kiel HJ, Wieland WF. Clinical results of the transurethreal resection and evaluation of superficial bladder carcinomas by means of fluorescence diagnosis after intravesical instillation of 5-aminolevulinic acid. J Endourol. 1999;13(2):117–121
  18. Koenig F, McGovern FJ, Larne R, Enquist H, Schomacker KT, Deutsch TF. Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced by 5-aminolaevulinic acid. BJU Int. 1999;83(1):129–135
  19. Riedl CR, Plas E, Pfluger H. Fluorescence detection of bladder tumors with 5-aminolevulinic acid. J Endourol. 1999;13:755–759
  20. De Dominicis C, Liberti M, Perugia G, et al. Role of 5-aminolevulinic acid in the diagnosis and treatment of superficial bladder cancer: improvement in diagnostic sensitivity. Urology. 2001;57(6):1059–1062
  21. Zaak D, Hofstetter A. The current diagnosis of superficial bladder cancer must be reconsidered. Urol Int. 2002;69(2):85–90
  22. Kriegmair M, Zaak D, Rothenberger KH, et al. Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy. J Urol. 2002;168(2):475–478
  23. Riedl CR, Daniltchenko D, Koenig F, Simak R, Loening SA, Pflueger H. Fluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancer. J Urol. 2001;165(4):1121–1123
  24. Filbeck T, Pichlmeier U, Knuechel R, Wieland WF, Roessler W. Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors. J Urol. 2002;168(1):67–71
  25. Denzinger S, Burger M, Walter B, et al. Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study. Urology. 2007;69(4):675–679
  26. Botteman MF, Pashos CL, Redaelli A, Laskin B, Hauser R. The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics. 2003;21(18):1315–1330
  27. Riley GF, Potosky AL, Lubitz JD, Kessler LG. Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis. Med Care. 1995;33(8):828–841
  28. Sangar VK, Ragavan N, Matanhelia SS, Watson MW, Blades RA. The economic consequences of prostate and bladder cancer in the UK. BJU Int. 2005;95(1):59–63
  29. Burger M, Zaak D, Stief CG, et al. Photodynamic diagnostics and noninvasive bladder cancer: is it cost-effective in long-term application? A Germany-based cost analysis. Eur Urol. 2007;52(1):142–147
  30. Hartmann A, Moser K, Kriegmair M, Hofstetter A, Hofstaedter F, Knuechel R. Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma. Am J Pathol. 1999;154(3):721–727
  31. Stenzl A, Hoetl L, Bartsch G. Fluorescence-assisted transurethral resection of bladder tumors: is it cost-effective?. Eur Urol. 2001;39(s5):1–216

PII: S1572-1000(08)00041-0

doi: 10.1016/j.pdpdt.2008.05.001

Photodiagnosis and Photodynamic Therapy
Volume 5, Issue 2 , Pages 153-158 , June 2008